IN8bio, Inc.

IN8bio, Inc.verified

INAB

Price:

$0.304

Market Cap:

$14.22M

IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of glioblastoma and solid tumors; and INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with acute leukemia undergoing hematopoietic stem cell transplantation. It also develops INB-400 and INB-300 that is in preclinical Phase for treatment of various solid tumor cancers. The company was formerly known as Incy...[Read more]

Industry

Biotechnology

IPO Date

2021-07-30

Stock Exchange

NASDAQ

Ticker

INAB

The Dividend Yield as of September 2024 (TTM) for IN8bio, Inc. (INAB) is 0%

According to IN8bio, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

IN8bio, Inc. (INAB) Historical Dividend Yield (quarterly & annually)

How has INAB Dividend Yield performed in the past?

The mean historical Dividend Yield of IN8bio, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), INAB's Dividend Yield was at its highest in in the March 2018 quarter at 0%. The Dividend Yield was at its lowest in in the March 2018 quarter at 0%.

Quarterly (TTM)
Annual

Average

0%

Median

0%

Minimum

0%

Maximum

0%

IN8bio, Inc. (INAB) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of IN8bio, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Dividend Yield = 0%

Minimum Annual Increase = 0%

Minimum Annual Dividend Yield = 0%

Quarterly (TTM)
Annual
YearDividend YieldChange
20230%0%
20220%0%
20210%0%
20200%0%
20190%0%

IN8bio, Inc. (INAB) Average Dividend Yield

How has INAB Dividend Yield performed in the past?

The current Dividend Yield of IN8bio, Inc. (INAB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0%

5-year avg

0%

10-year avg

0%

IN8bio, Inc. (INAB) Dividend Yield vs. Peers

How is INAB’s Dividend Yield compared to its peers?

IN8bio, Inc.’s Dividend Yield is less than Reviva Pharmaceuticals Holdings, Inc. (0%), less than Cue Biopharma, Inc. (0%), less than Lantern Pharma Inc. (0%), less than Gracell Biotechnologies Inc. (0%), less than Anixa Biosciences, Inc. (0%), less than INmune Bio, Inc. (0%), less than PolyPid Ltd. (0%), less than Zura Bio Limited (0%), less than Annexon, Inc. (0%), less than Icosavax, Inc. (0%), less than Wave Life Sciences Ltd. (0%), less than Gain Therapeutics, Inc. (0%), less than TFF Pharmaceuticals, Inc. (0%), less than aTyr Pharma, Inc. (0%), less than Palisade Bio, Inc. (0%), less than ContraFect Corporation (0%), less than Allarity Therapeutics, Inc. (0%), less than CNS Pharmaceuticals, Inc. (0%), less than Windtree Therapeutics, Inc. (0%),

Build a custom stock screener for IN8bio, Inc. (INAB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IN8bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

IN8bio, Inc. (INAB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like IN8bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Dividend Yield?

How can you use the Dividend Yield?

What is IN8bio, Inc.'s Dividend Yield?

How is the Dividend Yield calculated for IN8bio, Inc. (INAB)?

What is the highest Dividend Yield for IN8bio, Inc. (INAB)?

What is the 3-year average Dividend Yield for IN8bio, Inc. (INAB)?

What is the 5-year average Dividend Yield for IN8bio, Inc. (INAB)?

How does the current Dividend Yield for IN8bio, Inc. (INAB) compare to its historical average?